MedPath

Bexarotene

Bexarotene Gel, 1% Rx Only

Approved
Approval ID

2c21f361-e3d1-45a5-a6e7-df8164e3f90d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 29, 2023

Manufacturers
FDA

Amneal Pharmaceuticals NY LLC

DUNS: 123797875

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Bexarotene

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code69238-2088
Application NumberANDA215398
Product Classification
M
Marketing Category
C73584
G
Generic Name
Bexarotene
Product Specifications
Route of AdministrationTOPICAL
Effective DateDecember 29, 2023
FDA Product Classification

INGREDIENTS (5)

BEXAROTENEActive
Quantity: 10 mg in 1 g
Code: A61RXM4375
Classification: ACTIB
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQ
Classification: IACT
HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive
Code: 9XZ8H6N6OH
Classification: IACT
BUTYLATED HYDROXYTOLUENEInactive
Code: 1P9D0Z171K
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Bexarotene - FDA Drug Approval Details